Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Neuroscience"


25 mentions found


Bank of America reiterates Tesla as buy Bank of America said it's standing by its buy rating on the electric-vehicle maker. "We maintain our Buy rating and raise our PT from $1100 to $1,150." "We are initiating coverage of Live Nation with a Buy rating and $120 price target." "We are initiating coverage on EE with an Overweight rating." "We are initiating coverage of Integral Ad Science with a Buy rating and a $15 price target."
Persons: Tesla, TSLA, Morgan Stanley, Oppenheimer, Raymond James, Mizuho, Airbnb, Coinbase, Needham, Stephens, Jefferies, Ralph Lauren, Chegg Organizations: Argus, Boeing, " Bank of America, Bank of America, UBS, Nvidia, Dyne, JPMorgan, Catalyst Watch, Apple, Mizuho, Citi, BTC, Ethereum, Paramount, CBS, Deutsche Bank, Deutsche, Excelerate Energy, Stephens, Barclays, UMB, Corp, Contineum Locations: Base, Kansas City
A Peek Inside the Brains of ‘Super-Agers’
  + stars: | 2024-04-29 | by ( Dana G. Smith | ) www.nytimes.com   time to read: +1 min
When it comes to aging, we tend to assume that cognition gets worse as we get older. For a little over a decade, scientists have been studying a subset of people they call “super-agers.” These individuals are age 80 and up, but they have the memory ability of a person 20 to 30 years younger. Most research on aging and memory focuses on the other side of the equation — people who develop dementia in their later years. A paper published Monday in the Journal of Neuroscience helps shed light on what’s so special about the brains of super-agers. The biggest takeaway, in combination with a companion study that came out last year on the same group of individuals, is that their brains have less atrophy than their peers’ do.
Persons: that’s, we’re, , Emily Rogalski Organizations: University of Chicago, Neuroscience
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, US, on Wednesday, Dec. 27, 2023. Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and several new drugs posted sales growth. Two-thirds of savings are associated with drug research and development, Bristol Myers Squibb executives said during an earnings call on Thursday. Those deals come as Bristol Myers faces pressure to launch new drugs and offset the potential loss of revenue from top-selling treatments. Shares of Bristol Myers fell more than 1% in premarket trading Tuesday.
Persons: Bristol Myers, Samit Hirawat, Chris Boerner, Boerner, Revlimid Organizations: Bristol Myers Squibb, Bristol Myers, Karuna Therapeutics, SystImmune, Bristol, LSEG Locations: Cambridge, Cambridge , Massachusetts, Here's
While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is growing. Last week, Morgan Stanley analysts noted that it is the months leading up to an initial rate cut when biotech stocks outperform. Morgan Stanley also believes the case for biotech stocks is further reinforced by the financing environment and the outlook for mergers and acquisitions as well as upcoming innovation. The case for innovation Morgan Stanley also favors owning biotech stocks that have a strong drug platform even if the key catalyst of clinical trial data and FDA approvals are farther out. Rhythm ranks among the stocks rated overweight that Morgan Stanley favors in this category.
Persons: Morgan Stanley, Needham, Joseph Stringer, dealmaking, Stringer, erosive, it's, Phathom, GERD, LSEG, Merck, — CNBC's Michael Bloom Organizations: Federal Reserve, Nasdaq, Oncology, Immunology, Phathom Pharmaceutical, Pharmaceuticals, Phathom Pharmaceuticals, LSEG, Drug, Bristol Myers Squibb, Pfizer, Intellia Therapeutics, Rocket Pharmaceuticals Locations: New Jersey
That message included a link to a video on Xiaohongshu, a social media platform rapidly gaining steam in China. The student started her self-empowerment channel in November and has so far published eight videos and seven YouTube Shorts. The Xiaohongshu deepfakes of other YouTubers do the same. In a matter of about 10 minutes, BI found deepfake videos of at least five caucasian women on Xiaohongshu. But at least one Chinese deepfake version of Blakely has a different agenda to share on Xiaohongshu.
Persons: , Olga Loiek, Loiek, Vladimir Putin, Loeik, Weibo, someone's, Lyu Siwei, it's, Haibing Lu, they've, Xiaohongshu, Natasha, she's, Annie, Sophia Elena, Katyusha, China, Lana Blakely, Blakely, Elizabeth Filips, Serbia, Filips, Lyu, Vincent Conitzer, Conitzer, Lu, Lyu who's, he's, Roy, Ari Lightman, she'll Organizations: Service, Business, Kremlin, YouTube, WhatsApp, Facebook, Media, University at Buffalo, Santa Clara University, University of Pennsylvania, BI, Russia, Institute for, Oxford University, Social, Carnegie Mellon University Locations: Munich, China, Moscow, Ukraine, Santa, China's Heilongjiang, Germany, Xiaohongshu, Russian, Russia, Stockholm, Xiaohongshu London, Pakistan
Siskind is one of a growing number of entrepreneurs and executives seeking out psychedelics — including LSD, psilocybin mushrooms, ayahuasca, and MDMA — for work-related inspiration and guidance. AdvertisementA Manhattan psychedelic sound bathSarah Rose Siskind says one year after her psychedelic-induced revelation, work is going better than ever. When Siskind arrived at work on Monday, she called a staff meeting to share the company's new value-oriented direction. While Zillmer's breakthroughs came in Peru and with ayahuasca, these types of retreats for business professionals are popping up all over and with a variety of psychedelics. Beyond bottom linesThe location where Kiyumí Retreats will host a psychedelic retreat for business professionals later this year.
Persons: , Sarah Rose Siskind, she'd, I'd, psychedelics, Steve Jobs, Mike Bryk, Siskind, David Luke, psychedelics Henrik Zillmer, Michael Costuros, Henrik Zillmer, Zillmer, It's, John Gilmore, Gilmore, Gül, Dölen, Isabel Wiessner, AirHelp, Kiyumí, Bennet Zelner, Zelner, they'd, John Allison, Allison Organizations: Service, Business, University of Greenwich, Sun Microsystems, University of California, Federal University of Rio, University of Maryland Locations: New York City, Silicon, Peru, Mexico, Noho, Manhattan, Bay, London, Berlin, Berkeley, Federal University of Rio Grande de Norte, Brazil, Netherlands, Brooklyn
Elon Musk's startup Neuralink streamed a live video on Wednesday that showed a patient using the company's brain implant to move a mouse and play chess on a computer. A BCI is a system that deciphers brain signals and translates them into commands for external technologies. Dr. Nader Pouratian, chair of the Department of Neurological Surgery at UT Southwestern Medical Center, said researchers have been developing and studying BCI technology for years. It is not clear how many patients are participating in Neuralink's trial, or what the trial is trying to demonstrate. There is reason to be hopeful about Neuralink's technology, said Dr. Marco Baptista, chief scientific officer of the Christopher & Dana Reeve Foundation, which provides resources to people who have become paralyzed.
Persons: Elon, Noland Arbaugh, Musk, Arbaugh, there's, Neuralink, Nader Pouratian, we've, Pouratian, Marco Baptista, Christopher, Dana Reeve, " Baptista Organizations: BCI, Blackrock, Neuroscience, SpaceX, Department of Neurological, UT Southwestern Medical Center, CNBC, U.S . Food, Drug Administration, Dana Reeve Foundation, PubMed Locations: Brussels, Belgium, Synchron, U.S, Neuralink
Deutsche Bank reiterates Charles Schwab as buy Deutsche Bank raised its price target on the stock to $77 per share from $75. UBS reiterates Boeing as buy UBS said the risks are already priced in for Boeing shares. Loop reiterates Best Buy as buy Loop said the electronics giant is a "stealth housing play." UBS reiterates Micron as buy UBS said it is standing by its buy rating on the stock heading into earnings on Wednesday. UBS upgrades Cognex to buy from neutral UBS said the systems software company is "high quality growth at a discount."
Persons: Goldman Sachs, Charles Schwab, Bernstein, , Redburn, Cooper, Jefferies, ZM, Mizuho, Baird, KeyBanc, Raymond James, Morgan Stanley, Stephens, Guggenheim, Wells, Wells Fargo Organizations: Nvidia, Deutsche Bank, Northern Trust Deutsche Bank, Northern Trust, Apple, Google, Barclays, Cooper Companies, Citi, Honeywell, Honeywell International Inc, Union Pacific Corp, Mizuho, UBS, Boeing, Micron, TEAM, Logistics, Industries, JPMorgan, Systems, Bank of America, Avis Budget, OW, Equity, Accenture, Starbucks Locations: Snowflake, 2H24E, Truist
See itWhen you create a mental image of what you're trying to remember, you add more neural connections to it. Make what you're trying to remember something you can easily see in your mind's eye2. Use your imaginationPeople with the best memories have the best imaginations. People with the best memories have the best imaginations. If you don't get enough sleep, you'll go through the next day experiencing a form of amnesia.
Persons: Dwayne, Johnson, Lisa Genova, Taylor, aren't, you'll, Lisa Organizations: Harvard, New York Times, Bates College, Harvard University, PBS, NBC, CNN, NPR, TED, CNBC Locations: biopsychology
Jefferies likes these dividend-growing stocks for 2024
  + stars: | 2024-03-18 | by ( Michelle Fox | ) www.cnbc.com   time to read: +3 min
Investors searching for income could be well-rewarded by turning to dividend-growing stocks, according to Jefferies. "Consensus expects USA dividend growth to accelerate from 3.9% for 2023 to 6.2% for 2024, along with positive revisions," Peramunetilleke wrote in a note Wednesday. JPMorgan Chase , which has a 2.3% 12-month forward dividend yield, is the largest name on the list. AbbVie also made the list with a 12-month forward dividend of 3.5%. McDonald's , which has a 2.4% 12-month forward dividend, also made the cut.
Persons: Peramunetilleke, Jefferies, AbbVie, Robert Michael Organizations: Jefferies, JPMorgan Chase, Therapeutics
“They’re teenagers, at least in appearance, until they die.”Mexico's Lake Xochimilco is the only spot where axolotls are found in the wild. Daniel Cardenas/Anadolu/Getty ImagesWhile the wild axolotls of Lake Xochimilco have dwindled to near-extinction, countless axolotls have been bred for scientific laboratories and the pet trade. However, the axolotls you might find at a pet shop are different from their wild relatives in Lake Xochimilco. That means that the axolotl extinction crisis can’t simply be solved by dumping pet axolotls into Lake Xochimilco. (Plus, the pet axolotls likely wouldn’t fare well with the poor habitat conditions in the lake.)
Persons: Randal Voss, Voss, , ’ ”, Xolotl, “ ACK, uhl, ” Voss, Hector Vivas, they’re, Luis Zambrano, ” Zambrano, Daniel Cardenas, they’ve, Axolotls, Zambrano, axolotls, , ” Kate Golembiewski Organizations: CNN, University of Kentucky College of Medicine, , Aztecs, National Autonomous University of Mexico, Mexico City, International Union for Conservation of Nature, Axolotl, Amphibians Conservation, Anadolu, Getty Locations: Mexican, Xochimilco, Mexico City, It’s, Lake Xochimilco, Mexico, French, Europe, California , Maine , New Jersey, Washington, Minecraft, Chicago
After treatment with targeted deep brain stimulation, she hopes to walk out soon and, for the first time in her adult life, live independently, in her own apartment. Doctors used a tube that led into her stomach through her nose to give her food and gave her fluids intravenously. Deep brain stimulation for severe obsessive-compulsive disorder helped Julia Hum earn her high-school equivalency certificate last year. Refining deep brain stimulationHum had a deep brain stimulator implanted in 2021. Deep brain stimulation can be life-changing, but it doesn’t work equally well for everyone, and researchers say they’re getting closer to understanding why.
Persons: Julia Hum, Hum, , Doctors, it’s, ” Hum, Andreas Horn, “ I’ll, I’ll, Darin Dougherty, didn’t, they’re, ” Horn, Sameer Sheth, , Sheth, Dougherty, “ It’s, she’s, Dr, Sanjay Gupta, “ Hope Organizations: CNN, General Hospital, Doctors, Mass General Research Institute, Baylor College of Medicine, CNN Health Locations: Massachusetts, Houston
Eating regular, healthy meals, especially shared with loved ones , has also been linked with healthy aging, Thornton-Wood said. Strength training also helps minimize the loss of bone density, which is important for healthy aging, Worthington said. In particular, if you have a strong family history of heart disease, it's important to lay the foundation for a proactive heart health plan now." The American Heart Association recommends following the DASH diet , which stands for Dietary Approaches to Stop Hypertension, for heart health. AdvertisementShe said that giving up smoking is the single most important thing you can do for your heart health.
Persons: It's, , Bryan Johnson, Elaine LaLanne, it's, Clare Thornton, Wood, Thornton, Luke Worthington, Worthington, Nicole Harkin, Harkin, Joanne Whitmore, Whitmore, Charles Puza, Puza, Dale Bredesen, Bredesen Organizations: Service, Business, Getty, Disease Control, Cardiology, American Heart Association, British Heart Foundation, American Academy of Dermatology, Buck Institute for Research, Aging Locations: Thornton, barre, San Francisco, New York, California
The Food and Drug Administration has decided to delay action on a closely watched Alzheimer’s drug, donanemab, which the agency was widely expected to approve this month. will instead require donanemab to undergo the scrutiny of a panel of independent experts, the drug’s maker, Eli Lilly and Company, said Friday. The decision is likely to surprise many Alzheimer’s experts, doctors and patients who had expected the medication would soon be on the market. The F.D.A.’s move was startling to the company, which had been planning for the agency to greenlight the drug during the first quarter of this year. “We were not expecting this,” Anne White, an executive vice president of Lilly and president of its neuroscience division, said in an interview.
Persons: Eli Lilly, , Lilly, ” Anne White, Organizations: Drug Administration Locations: donanemab
Eli Lilly headquarters in Indianapolis, Indiana, US, on Wednesday, May 3, 2023. Eli Lilly said Friday that the Food and Drug Administration has pushed back its approval decision deadline for the drugmaker's experimental Alzheimer's treatment donanemab in a surprise move. The agency plans to call a last-minute meeting of its outside advisors to further review the treatment's safety and efficacy in a late-stage trial, Eli Lilly said. It's another setback for Eli Lilly, which is racing to compete with Biogen and Eisai. In 2021, the FDA approved an earlier, ill-fated Alzheimer's drug called Aduhelm from Biogen and Eisai, despite a negative recommendation from the agency's advisory panel.
Persons: Eli Lilly, Eli Lilly's, Leqembi, Anne White Organizations: and Drug Administration, FDA Locations: Indianapolis , Indiana, Biogen
CNN —There is still much researchers don’t know about popular weight loss medications — and those lack of studies could have consequences for eating disorders, according to experts. As the medication become more available, experts said they worry about the impact of these weight loss products on eating disorders. “The eating disorder field is hard because we’re just ignored.”Can these drugs treat binge eating disorder? Binge eating disorder is the most common eating disorder. “A lot of eating disorders do begin with restricted food intake and weight loss,” she said.
Persons: , Aaron Keshen, Jennifer Gaudiani, Susan McElroy, Linda, Harry Fath, McElroy, , ” McElroy, ” Keshen, it’s, Keshen, Gaudiani, ” Gaudiani, “ it’s, , haven’t Organizations: CNN, Nova, Disorder, National Association, Disorders, Gaudiani Clinic, Lindner, of HOPE, University of Cincinnati College of Medicine, International Locations: Nova Scotia, Dalhousie University’s, Halifax , Nova Scotia, United States, Denver, Minnesota
Read previewAxel Bouchon cofounded Matter Neuroscience in 2019 after leading the venture arms of pharma giants Moderna and Bayer. AdvertisementMatter has emerged from stealth with $26 million from ARCH Venture Partners, Polaris Partners, Exor Ventures, and Collaborative Fund, Business Insider has learned exclusively. That $26 million includes an initial seed round led by Polaris Partners and a Series A round led by ARCH Venture Partners. The startup views itself now as a consumer biotech startup, Bouchon said. Here's the 17-slide pitch deck Matter used to raise $26 million.
Persons: , Axel Bouchon, Bouchon Organizations: Service, pharma, Moderna, Bayer, Business, Venture Partners, Polaris Partners, Exor Ventures, Fund, Brain Imaging, Icahn School of Medicine Locations: Maastricht, Netherlands, Mount Sinai, Seoul, South Korea
For years, the Duke professor Dan Ariely was at the top of his game. Three professors behind the blog Data Colada reported evidence of fake data in a 2012 paper Ariely coauthored on honesty pledges. "When people do take a risk and they succeed, everybody enjoys it," Ariely told BI. In 2010, Ariely told NPR that two dentists examining the same teeth for cavities would agree only 50% of the time, citing research from Delta Dental. While the board originally said it would "unanimously stand in support of President Gay," Gay stepped down in early January in response to the backlash.
Persons: Dan Ariely, Dan Ariely's, Jesse L, Martin, Ariely, Duke, sniffed, they'd, James B, , they're, Francesca Gino, Ariely's, Marc Tessier Lavigne, Claudine Gay, Prince Andrew ., he's, Brad Swain, He's, Gordon Pennycook, Sean Gallup, Nick Brown, who's, Michael Sanders, who'd, Sanders, Gino, Aimee Drolet Rossi, Rossi, she'd, Amir, wasn't, hasn't, I've, haven't, isn't, would've, Claudine Gay's, Andrew Lichtenstein, Bill Ackman, Gay, Harvard, doesn't, Gay should've, Brown, Cornell Watson, who've, wouldn't Organizations: Google, NBC, UCLA, Duke, Business, Harvard Business, TED, Irrational, Cornell, Getty, Burda, King's College London, New York Times, NPR, Delta Dental, Higher Education, Hartford, Ariely, Harvard, University, Universities, BI, Colorado's, King's College Locations: Buckingham Palace, British, Hartford, Gaza, Montana
Test tubes are seen in front of a displayed AbbVie logo in this illustration taken on May 21, 2021. AbbVie on Tuesday said longtime executive Robert Michael will become the company's new CEO, replacing Richard Gonzalez. Michael, who is AbbVie's president and chief operating officer, will become the company's second-ever CEO on July 1. Gonzalez, who has led the company since it spun out from Abbott Laboratories in 2013, will retire and become AbbVie's executive chairman. Now is the opportune time to hand the CEO role over to Rob," Gonzalez said in a release.
Persons: AbbVie, Robert Michael, Richard Gonzalez, Michael, Gonzalez, Rob Organizations: Abbott Laboratories, AbbVie, CNBC PRO Locations: Humira
There's been a lot of chatter about the mental health crisis since the Covid-19 pandemic. Attention to a long-time crisis The mental health crisis is nothing new. However, there has also been a growing awareness and acceptance of mental health illnesses over the past decade, said Canaccord Genuity analyst Richard Close. "There's been recognition that mental health has a significant impact on a person's overall health," he said. "This is the mental health moment," said Dr. Ken Duckworth, NAMI's chief medical officer and author of "You Are Not Alone: The NAMI Guide to Mental Health."
Persons: There's, Covid, Peter Micca, AbbVie, Emraclidine, Myers Squibb, Karuna, Marc Goodman, Canaccord, Richard Close, MacKenzie Scott, Ken Duckworth, NAMI, Deloitte's Micca, William Blair, Myles Minter, Minter, Auvelity, Leerink's Goodman, Ashwani Verma, Verma, Goodman, BioHaven, Cerevel, Neumora, tardive, David Song, BetterHelp, psychedelics Johnson, Johnson, Spravato, Blair's Minter, Axsome, Micca, Michael Bloom Organizations: Institute for Health Metrics, Deloitte, Cerevel Therapeutics, Karuna Therapeutics, Bristol Myers, Leerink Partners, Centers for Disease Control, National Alliance, Mental, Mental Health, Wall Street, Therapeutics, Neumora Therapeutics, UBS, Karuna, Cellular Therapies, Xenon Pharmaceuticals, Neurocrine Biosciences, Acadia Pharmaceuticals, Tema Neuroscience, Axsome Therapeutics, Acadia Healthcare, BetterHelp, CNBC, pharma, Cellular Locations: Covid, Bristol, XEN1101, Acadia, Tema
My family sometimes thinks we're spoiling our children, but that doesn't change how I parent. I’m a mom of three girls aged seven and under, and I feel confident in the way my husband and I parent. I don’t think I’m spoiling my children — I think I’m setting them up for long-term mental and emotional well-being. AdvertisementI have grace for the way my family has judged my parentingIt's common in our culture to prioritize productivity over well-being. I might not be parenting perfectly, but I’m parenting on purpose.
Persons: I've, I’m, I’ve, There’s, Janet Lansbury, RIE, I’d Organizations: Infant Educators
Shanker also raised his price target to $80 from $75, suggesting nearly 34% downside from Friday's close. — Spencer Kimball 8:16 a.m.: Loop Capital upgrades Corteva, touts growth acceleration in 2025 Corteva's stronger-than-expected 2024 full-year guidance will jumpstart a period of strong growth, according to Loop Capital. The firm upgraded the agricultural chemicals company to buy from hold and increased its price target to $65 from $57. Analyst Jay Sole upgraded Urban to neutral from sell and upped his 12-month price target by $20 to $41. Kaufman's $183 price target indicates roughly 6.3% downside for shares, which have fallen more than 18% over the past year.
Persons: headwinds, Morgan Stanley downgrades XPO, Morgan Stanley, Ravi, Shanker, — Michelle Fox, Julien Dumoulin, Smith, Duke's, — Spencer Kimball, Chris Kapsch, Kapsch, Brian Evans, Cassie Chan, they'll, Chan, , Jay Sole, URBN, Sole, Urban's, — Pia Singh, Filippo Falorni, Falorni, Hershey, Stanley, Pamela Kaufman, Kaufman's, Hershey's, Kaufman, Graham Doyle, Doyle, Piper Sandler, David Amsellem, Amsellem, Amsellam, Christopher Horvers, Jan, Horvers, Fred Imbert, Dan Levy, Levy Organizations: CNBC, Barclays, Automotive, JPMorgan, Corp, Bank of America, Bank of America downgrades Duke Energy, Duke Energy, Duke, Wall, America, UBS, Urban Outfitters, Free People, Urban, Citi, PepsiCo, Citi Research, Pepsi, Hershey, GE Healthcare Technologies, UBS GE Healthcare Technologies, Pharmaceutical, Teva Pharmaceutical, Federal, Barclays downgrades Rivian, Rivian Automotive, North American EV Locations: Bank of America downgrades, GEHC, David Amsellem U.S
Here are five expert tips for keeping your mind sharp into your 80s and beyond. download the app Email address Sign up By clicking “Sign Up”, you accept our Terms of Service and Privacy Policy . With the President's cognitive capabilities making headlines again, here are five top tips from experts to keep your brain sharp for when you get to be Biden's age. A 2019 study concluded that tea drinkers have higher cognitive functions and better-organized brain regions when compared to non-tea drinkers. "But learning new things helps with brain plasticity, and if you are able to keep using your brain in new ways, you can have better mental outcomes as you age."
Persons: , Joe Biden's, Biden, you've, Talia Lerner, Jason Shepherd Organizations: Service, Business, Blue Zone, Northwestern University, University of Utah Locations: Ikaria
Mamadi Doumbouya for The New York Times Talk A Leading Memory Researcher Explains How to Make Precious Moments LastOur memories form the bedrock of who we are. Tell me more about what you mean when you say “illusion.” I probably overstated it with the word “illusion,” but there is an illusionary component. But if you think about it from an evolutionary perspective, memory, often, is educated guesses by the brain about what’s important. You know, the training environment I was in was very down on psychoanalysis, but it always comes back to memory. We have these little compartments that are rooted somewhat in memory that we can access at different moments.
Persons: Mamadi Doumbouya, , Charan Ranganath, Davis, Ranganath, ” Ranganath, You’re, , shoplifted, there’s, We’re, Charan, UC Davis, you’re, you’ve, Sasha Bakhter, It’s, hadn’t Organizations: The New York Times, University of California, UC, Smiths, UC Davis Locations: Davis
Dry January “was the perfect eye-opener.”Now sober, Montejano has adopted several tactics to keep herself on track: talking to a therapist, journaling and drinking nonalcoholic beverages like mocktails. By comparison, a 12-ounce glass of beer contains about 5% alcohol, according to the CDC. “The nonalcoholic beverages have a lot of the cues that are associated with real alcoholic beverages,” she said. “Are you reaching those goals with nonalcoholic beverages?” she said. Ultimately, going sober can have social ramifications, so it’s important to surround yourself with people who can support you.
Persons: Corrina Montejano, Montejano, , , Ginger Hultin, nonalcoholic, Hilary Sheinbaum, Molson Coors, ” Sheinbaum, Hultin, Dr, Lara Ray, Dana Ellis Hunnes, you’re, Hunnes, Ray, they’re, Sanjay Gupta, I’ve, ’ ”, “ You’ve, Journaling, ” Montejano Organizations: CNN, US Centers for Disease Control, Heineken, Molson, US Department of, Tobacco Tax, Trade Bureau, UCLA, World Health Organization, ” WHO, UCLA Medical Center, US Food and Drug Administration, mocktails, CNN Health Locations: San Francisco, Seattle
Total: 25